(NASDAQ: DMTK) Dermtech's forecast annual revenue growth rate of 28.46% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.47%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.87%.
Dermtech's revenue in 2024 is $15,296,000.On average, 2 Wall Street analysts forecast DMTK's revenue for 2024 to be $680,350,655, with the lowest DMTK revenue forecast at $675,157,139, and the highest DMTK revenue forecast at $685,544,171.
In 2025, DMTK is forecast to generate $837,887,321 in revenue, with the lowest revenue forecast at $837,887,321 and the highest revenue forecast at $837,887,321.